SignalHF vs FibriCheck
AI Verdict
Choose SignalHF if…
Choose SignalHF if your cardiology practice manages a significant population of patients with cardiac implantable electronic devices (CIEDs) and you require an FDA-cleared AI solution for proactive prediction of heart failure hospitalizations. This tool is ideal for enabling early, data-driven interventions to prevent acute events and optimize care plans for high-risk patients.
View SignalHF →Choose FibriCheck if…
Choose FibriCheck if you need a flexible, patient-centric solution for remote heart rhythm monitoring and arrhythmia detection using a smartphone. This tool is best suited for empowering patients to self-monitor their cardiac health, providing immediate insights, and allowing healthcare providers to oversee a broader patient population for potential arrhythmias without the need for specialized implantable devices.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SignalHF | FibriCheck |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | SaaS | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck offers a patient-facing mobile application that leverages the ubiquitous smartphone camera, making it highly accessible and user-friendly for a broad audience, including older demographics. While SignalHF focuses on streamlining workflows for healthcare professionals, FibriCheck's direct patient interaction via a familiar device provides superior broad usability.
Clinical Value
SignalHFSignalHF provides a predictive AI algorithm that forecasts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention. This proactive approach, supported by evidence of reduced mortality and hospitalization length, addresses a more critical and complex clinical outcome compared to FibriCheck's arrhythmia detection.
Pricing & Value
FibriCheckFibriCheck offers transparent and detailed pricing for both end-users and healthcare providers, including monthly/yearly subscriptions and short-term options for doctor-prescribed use. This clarity allows for easy assessment of its value proposition. SignalHF's 'contact for pricing' model lacks this transparency, making a direct comparison of value difficult without further engagement.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, albeit with different focuses. SignalHF excels in centralizing and standardizing data from diverse cardiac implantable electronic devices across manufacturers, crucial for large cardiology departments. FibriCheck offers robust API integration with EHRs and RPM platforms, has been deployed in over 100 healthcare systems, and is designed for scalability to millions of patients.
Innovation
SignalHFSignalHF's FDA-cleared predictive AI algorithm for heart failure hospitalization, which is manufacturer-agnostic across various CIEDs, represents a more advanced and clinically impactful innovation in AI-driven decision support. Its ability to forecast critical events weeks in advance for proactive intervention is a significant leap in preventative care. While FibriCheck's smartphone-based PPG is innovative for accessibility, SignalHF addresses a more complex predictive challenge.
Support & Docs
FibriCheckFibriCheck provides a comprehensive Help Center with user manuals, FAQs, and educational materials for various user types, along with developer documentation and an optional medical expert review service. SignalHF's available information is limited to general mentions of 'instructions for use' without detailing specific support channels or a comprehensive documentation portal.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SignalHF | FibriCheck |
|---|---|---|
| Name | SignalHF | FibriCheck |
| Company | Implicity | Qompium nv |
| Primary Function | Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices. | Helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Data Source/Technology | Analyzes data from various CIEDs (pacemakers, ICDs, CRTs), physiological data, demographics, lead measurements, episodes, and therapies. | Smartphone camera-based PPG technology for heart rhythm measurement; AI-powered algorithm for arrhythmia detection and analysis. |
| Target Condition(s) | Heart failure hospitalizations | Arrhythmias, Atrial Fibrillation (AFib) |
Videos
Demos, reviews, and walkthroughs featuring SignalHF and FibriCheck.